Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
Tempus Ai,Inc.Tempus Ai,Inc.(US:TEM) Businesswire·2025-10-01 16:24

公司动态 - Ambry Genetics公司宣布推出经过改进的、与电子健康记录系统集成的乳腺癌风险评估解决方案 [1]